Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Outset Medical Inc
OM
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$4.37
0.025
0.58%
Ult. Agg.: Oct 28, 10:37 AM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 7 giorni da adesso in mer nov 4th, dopo la chiusura del mercato
Conference call:
Conference call programmata per tra 7 giorni alle 4:30 PM
Clicca per vedere il webcast
Outset Medical Financials
Outset Medical (OM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.633M Est
Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.633 million estimate.
Benzinga Newsdesk
PRO
Outset Medical Q2 Adj. EPS $(0.80) Misses $(0.72) Estimate, Sales $31.635M Beat $29.833M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 4.76 percent increase over losses of $(0.84) per share from
Benzinga Newsdesk
PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.767M Est
Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.767 million estimate.
Benzinga Newsdesk
PRO
Outset Medical Q1 Adj. EPS $(0.83) Misses $(0.79) Estimate, Sales $27.863M Miss $28.900M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.79) by 5.06 percent. This is a 74.38 percent increase over losses of $(3.24) per share from the
Benzinga Newsdesk
Outset Medical Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Outset Medical Sees FY2026 Sales $125.000M-$130.000M vs $127.650M Est
Outset Medical (NASDAQ:OM) sees FY2026 sales of $125.000 million-$130.000 million vs $127.650 million analyst estimate.
Benzinga Newsdesk
